Skip to main content

MSAC 1623: ADAR Commentry for LuxturnaTM (voretigene neparvovec) for the treatment of biallelic RPE-65-mediated Inherited Retinal Dystrophies (CHERE)

Project Member(s): Goodall, S., De Abreu Lourenco, R., Vargas Parada, C., Arora, S.

Funding or Partner Organisation: Commonwealth Department of Health (Commonwealth Department of Health and Aged Care: C)
Commonwealth Department of Health (Commonwealth Department of Health and Aged Care: C)

Start year: 2020

FOR Codes: Health Economics, Evaluation of Health Outcomes